RMEI Continuing Medical Education Neuroscience

Neuroscience CE Activities

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

0.75 CE Credit(s)

Spinal Muscular Atrophy: An Interprofessional Approach

0.75 CE Credit(s)

Realizing the Promise of Interprofessional Care and Collaboration in Multiple Sclerosis

0.5 CE Credit(s)

Case-based Discussion on the Interprofessional Management of Non-Motor Symptoms in Patients with Parkinson’s Disease

CE Credit Expired

Neuroscience blog

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.

Neuroscience
Blog

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.

Neuroscience
Blog

RMEI DECISION SUPPORT AIDS

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience
Decision Support Aid

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience, Psychiatry
Decision Support Aid

LATEST NEUROSCIENCE ARTICLES

Latest Neuroscience Articles

Progress in the Development of N-of-1 Therapy May 15, 2025
Musunuru and colleagues1 describe in the Journal an innovative approach in which gene editing is applied in the treatment of a very rare disease, the severe urea-cycle disorder carbamoyl-phosphate synthetase 1 (CPS1) deficiency, which is usually fatal in early infancy in approximately half the infants who...
Peter Marks
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1 May 15, 2025
In this phase 2 randomized, placebo-controlled trial involving 112 participants with narcolepsy type 1, oveporexton significantly improved measures of wakefulness, sleepiness, and cataplexy over a period of 8 weeks.
Yves Dauvilliers, Giuseppe Plazzi, Emmanuel Mignot, Gert Jan Lammers, Rafael del Río Villegas, Ramin Khatami, Mitsutaka Taniguchi, Anson Abraham, Yaming Hang, Harisha Kadali, Marta Lamberton, Sarah Sheikh, Ellie Stukalin, Rachel Neuwirth, Todd J. Swick, Shinichiro Tanaka, Christian von Hehn, Philipp von Rosenstiel, Hao Wang, Alice Cai, Melissa Naylor, Tina Olsson
Science behind the Study: Targeting Orexin Receptors to Treat Narcolepsy May 15, 2025
The author describes the scientific foundations of a trial of an orexin agonist to treat narcolepsy.
Clifford B. Saper

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021